AVGO vs LXRX · P/E 87, rev $63.89B vs rev $21.8M
Broadcom Inc (AVGO) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock E. Tan.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported AVGO revenue for 2025-11-02 was $63.89B. Net income was $23.13B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the AVGO and LXRX stock pages for the full models.
Not investment advice.